Qualigen Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2014 to Q3 2024.
  • Qualigen Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.27M, a 54.3% increase year-over-year.
  • Qualigen Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.71M, a 40% increase year-over-year.
  • Qualigen Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$11.3M, a 23.4% increase from 2022.
  • Qualigen Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$14.8M, a 34.9% increase from 2021.
  • Qualigen Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$22.7M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$6.71M -$1.27M +$1.51M +54.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$8.21M -$1.74M +$1.86M +51.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$10.1M -$1.42M +$1.23M +46.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-07-02
Q4 2023 -$11.3M -$2.27M -$133K -6.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-08
Q3 2023 -$11.2M -$2.78M +$692K +19.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$11.9M -$3.6M +$540K +13% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$12.4M -$2.65M +$2.36M +47.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-07-02
Q4 2022 -$14.8M -$2.14M +$2.51M +53.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-08
Q3 2022 -$17.3M -$3.47M +$1.34M +27.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$18.6M -$4.14M +$3.25M +44% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$21.9M -$5.01M +$804K +13.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$22.7M -$4.65M Oct 1, 2021 Dec 31, 2021 10-K 2023-05-02
Q3 2021 -$4.81M -$1.09M -29.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$7.39M -$4.83M -188% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$5.81M -$5.03M -642% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$12.3M -$3.72M -$3.43M -1184% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$8.89M -$2.57M -$2.04M -389% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$6.85M -$784K +$3.99M +83.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$10.8M -$5.25M +$2.33M +30.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-31
Q3 2019 -$13.2M -$290K +$4.37M +93.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$17.5M -$525K +$3.08M +85.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$20.6M -$4.78M -$2.74M -134% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$17.9M -$7.58M -$5.34M -239% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 -$12.5M -$4.66M -$2.65M -131% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$9.9M -$3.61M -$1.64M -83.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$8.26M -$2.04M -$357K -21.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$7.9M -$2.24M +$5.36M +70.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$13.3M -$2.01M +$1.52M +43.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$14.8M -$1.97M +$2.19M +52.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$17M -$1.68M +$1.47M +46.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$18.4M -$7.6M -$5.3M -230% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$13.1M -$3.54M -$431K -13.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$12.7M -$4.16M -$2.06M -97.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$10.7M -$3.15M -$1.75M -126% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$8.91M -$2.3M Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 -$3.11M -$2.85M -1124% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$2.1M -$1.71M -444% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$1.4M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2014 -$254K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$386K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.